论文部分内容阅读
目的:观察成人支原体肺炎采用莫西沙星治疗的临床疗效。方法:选取某院收治的支原体肺炎患者共48例作为研究对象,采取等距随机抽样法分为对照组与研究组各24例,观察组患者采用莫西沙星药物治疗,对照组采用抗生素药物治疗。结果:观察组患者的平均退热时间为(3.21±1.02)天,3天内退热例数为20例,退热率为83.33%,病情恢复为(2.37±1.12)天,静脉抗生素使用时间(5.17±3.43)天,住院时间为(7.02±5.37)天,与对照组相比差异均具有统计学意义(P<0.05)。结论:莫西沙星药物对成人支原体肺炎有良好的治疗效果,值得临床推广应用。
Objective: To observe the clinical efficacy of moxifloxacin in adults with mycoplasma pneumonia. Methods: A total of 48 patients with mycoplasma pneumonia admitted in a hospital were selected as the study subjects. The subjects were divided into the control group and the study group with 24 cases in each group. The patients in the observation group were treated with moxifloxacin, while the patients in the control group were treated with antibiotics . Results: In the observation group, the average time of fever was (3.21 ± 1.02) days, the number of fever was 20 in 3 days, the rate of fever was 83.33%, the condition was (2.37 ± 1.12) days, the duration of intravenous antibiotics 5.17 ± 3.43) days, hospital stay was (7.02 ± 5.37) days, the difference was statistically significant compared with the control group (P <0.05). Conclusion: Moxifloxacin has a good therapeutic effect on mycoplasma pneumonia in adults, which is worthy of clinical application.